SK Biopharmaceuticals said on the 2nd it will acquire 128 NVIDIA B200 GPUs, AI
accelerators to support AI-driven drug discovery and development. The devices
will be provisioned via SK Telecom-built domestic data cluster HAEIN under a 17
billion won contract structured as an annual subscription, supplying the company
with AI infrastructure. SK Biopharmaceuticals said it will apply AI across
stages from candidate discovery to development and open innovation; if fully
leveraged, AI could shorten experiments and analysis and accelerate a process
that typically takes more than 10 years.
